The biochemistry and medical significance of the flavonoids

BH Havsteen - Pharmacology & therapeutics, 2002 - Elsevier
Flavonoids are plant pigments that are synthesised from phenylalanine, generally display
marvelous colors known from flower petals, mostly emit brilliant fluorescence when they are …

[PDF][PDF] Phase II drug metabolizing enzymes

P Jancova, P Anzenbacher… - Biomed Pap Med Fac Univ …, 2010 - Citeseer
Background. Phase II biotransformation reactions (also 'conjugation reactions') generally
serve as a detoxifying step in drug metabolism. Phase II drug metabolising enzymes are …

Bioaccessibility and bioavailability of phenolic compounds

F Shahidi, H Peng - Journal of Food Bioactives, 2018 - isnff-jfb.com
Modern epidemiological and interventional studies have demonstrated that various
bioactivities including antioxidant, antiproliferative, immune-regulatory, hormonal-regulation …

Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites

M Monagas, M Urpi-Sarda, F Sánchez-Patán… - Food & function, 2010 - pubs.rsc.org
Flavan-3-ols, occurring in monomeric, as well as in oligomeric and polymeric forms (also
known as condensed tannins or proanthocyanidins), are among the most abundant and …

Review of the flavonoids quercetin, hesperetin, and naringenin. Dietary sources, bioactivities, bioavailability, and epidemiology

I Erlund - Nutrition research, 2004 - Elsevier
The bioactivities, dietary sources, bioavailability, metabolism, and epidemiology of 3
flavonoids, quercetin, hesperetin, and naringenin, are reviewed. The use of their plasma …

Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios

JA Williams, R Hyland, BC Jones, DA Smith… - Drug Metabolism and …, 2004 - ASPET
Glucuronidation is a listed clearance mechanism for 1 in 10 of the top 200 prescribed drugs.
The objective of this article is to encourage those studying ligand interactions with UDP …

UDP-glucuronosyltransferases and clinical drug-drug interactions

TKL Kiang, MHH Ensom, TKH Chang - Pharmacology & therapeutics, 2005 - Elsevier
UDP-glucuronosyltransferase (UGT) enzymes catalyze the conjugation of various
endogenous substances (eg, bilirubin) and exogenous compounds (eg, drugs). The human …

Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics

CM Ulrich, J Bigler, JD Potter - Nature Reviews Cancer, 2006 - nature.com
Aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) show indisputable
promise as chemopreventive agents. Possible targets include cancers of the colon, stomach …

A comprehensive review of UDP-glucuronosyltransferase and esterases for drug development

S Oda, T Fukami, T Yokoi, M Nakajima - Drug metabolism and …, 2015 - Elsevier
UDP-glucuronosyltransferase (UGT) and esterases are recognized as the most important
non-P450 enzymes because of their high contribution to drug metabolism. UGTs catalyze …

UDP-glucuronosyltransferases

CD King, GR Rios, MD Green… - Current drug …, 2000 - ingentaconnect.com
Glucuronidation represents a major pathway which enhances the elimination of many
lipophilic xenobiotics and endobiotics to more water-soluble compounds. The UDP …